Figure 5. NBL1 inhibits PDGFRβ-p38MAPK signalling cascade activated by PDGF-BB in human PASMCs.
Treated the human PASMCs with PDGF-BB for 30 min and following pretreatment with NBL1 by western blotting (A) and densitometric analysis in (B). GAPDH was used as the loading protein. Data represent as mean ± S.E.M. (N=3). *P<0.05, **P<0.01, compared with control, ##P<0.01, compared with PDGF-BB treatment.